These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 3013628)

  • 1. Clinical uses of nalidixic acid analogues: the fluoroquinolones.
    Høiby N
    Eur J Clin Microbiol; 1986 Apr; 5(2):138-40. PubMed ID: 3013628
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical use of the quinolones.
    Neu HC
    Lancet; 1987 Dec; 2(8571):1319-22. PubMed ID: 2890913
    [No Abstract]   [Full Text] [Related]  

  • 3. Quinolone antimicrobial agents in acute exacerbations of chronic bronchitis.
    Maesen FP; Davies BI; Teengs JP; Baur C
    Eur J Respir Dis Suppl; 1986; 146():585-90. PubMed ID: 3465584
    [No Abstract]   [Full Text] [Related]  

  • 4. Quinolones.
    Shah PM
    Prog Drug Res; 1987; 31():243-56. PubMed ID: 3326031
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro activity, pharmacokinetics, clinical safety and therapeutic efficacy of enoxacin in the treatment of patients with complicated urinary tract infections.
    Naber KG; Sörgel F; Gutzler F; Bartosik-Wich B
    Infection; 1985; 13(5):219-24. PubMed ID: 2933340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The comparative pharmacokinetics of five quinolones.
    Wise R; Lister D; McNulty CA; Griggs D; Andrews JM
    J Antimicrob Chemother; 1986 Nov; 18 Suppl D():71-81. PubMed ID: 3468102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quinolones in the treatment of serious infections.
    Webster A; Gaya H
    Rev Infect Dis; 1988; 10 Suppl 1():S225-33. PubMed ID: 3279496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quinolones in the treatment of bronchopulmonary infections.
    Thys JP
    Rev Infect Dis; 1988; 10 Suppl 1():S212-7. PubMed ID: 3279495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fluoroquinolones].
    Baykal M; Akalin E
    Mikrobiyol Bul; 1987 Apr; 21(2):151-7. PubMed ID: 3482120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans.
    Hooper DC; Wolfson JS
    Antimicrob Agents Chemother; 1985 Nov; 28(5):716-21. PubMed ID: 2936302
    [No Abstract]   [Full Text] [Related]  

  • 11. Review of the 4-quinolones.
    Eggleston M; Park SY
    Infect Control; 1987 Mar; 8(3):119-25. PubMed ID: 3553053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in vitro studies with 4-quinolone antimicrobials.
    Felmingham D; O'Hare MD; Robbins MJ; Wall RA; Williams AH; Cremer AW; Ridgway GL; Grüneberg RN
    Drugs Exp Clin Res; 1985; 11(5):317-29. PubMed ID: 2941259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic contribution of the new quinolones].
    Wolff M
    Rev Prat; 1987 Apr; 37(21):1209-14. PubMed ID: 3474759
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative in vitro activity of seven quinolones against 100 clinical isolates of Clostridium difficile.
    Delmee M; Avesani V
    Antimicrob Agents Chemother; 1986 Feb; 29(2):374-5. PubMed ID: 2940968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative antimicrobial activity of enoxacin, ciprofloxacin, amifloxacin, norfloxacin and ofloxacin against 177 bacterial isolates.
    Bassey CM; Baltch AL; Smith RP
    J Antimicrob Chemother; 1986 May; 17(5):623-8. PubMed ID: 2941401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of the quinolones in volunteers: a proposed dosing schedule.
    Wise R; Griggs D; Andrews JM
    Rev Infect Dis; 1988; 10 Suppl 1():S83-9. PubMed ID: 3162327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New oral quinolone compounds in chronic bronchitis].
    Davies BI; Maesen FP; Teengs JP; Baur C
    Infection; 1986; 14 Suppl 1():S73-8. PubMed ID: 2937739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Biotransformation of selected gyrase inhibitors].
    Borner K; Lode H
    Infection; 1986; 14 Suppl 1():S54-9. PubMed ID: 3007367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The comparative in-vitro activity of eight newer quinolones and nalidixic acid.
    King A; Phillips I
    J Antimicrob Chemother; 1986 Nov; 18 Suppl D():1-20. PubMed ID: 3468100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The adverse effects of fluoroquinolones.
    Smith CR
    J Antimicrob Chemother; 1987 Jun; 19(6):709-11. PubMed ID: 3475267
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.